Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewTM 5275 sodium salt
Description: Plasminogen activator inhibitor-1 (PAI-1) inhibitor; orally bioavailable
Chemical Name: 5-Chloro-2-[[2-[2-[4-(Diphenylmethyl)-1-piperazinyl]-2-oxoethoxy]acetyl]amino]benzoic acid sodium salt
Purity: ≥98% (HPLC)
Biological Activity for TM 5275 sodium salt
TM 5275 sodium salt is a plasminogen activator inhibitor-1 (PAI-1) inhibitor. Orally bioavailable.
Compound Libraries for TM 5275 sodium salt
TM 5275 sodium salt is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
Technical Data for TM 5275 sodium salt
| M. Wt | 543.97 |
| Formula | C28H27ClN3NaO5 |
| Storage | Store at +4°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 1103926-82-4 |
| PubChem ID | 53240409 |
| InChI Key | JSHSGBIWNPQCQZ-UHFFFAOYSA-M |
| Smiles | O=C(COCC(NC4=C(C(O[Na])=O)C=C(Cl)C=C4)=O)N1CCN(C(C3=CC=CC=C3)C2=CC=CC=C2)CC1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for TM 5275 sodium salt
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 54.4 | 100 |
Preparing Stock Solutions for TM 5275 sodium salt
The following data is based on the product molecular weight 543.97. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.84 mL | 9.19 mL | 18.38 mL |
| 5 mM | 0.37 mL | 1.84 mL | 3.68 mL |
| 10 mM | 0.18 mL | 0.92 mL | 1.84 mL |
| 50 mM | 0.04 mL | 0.18 mL | 0.37 mL |
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets for TM 5275 sodium salt
References for TM 5275 sodium salt
References are publications that support the biological activity of the product.
Yamaoka et al (2011) Structure-activity relationships of new N-acylanthranilic acid derivatives as plasminogen activator inhibitor-1 inhibitors. Chem.Pharm.Bull. 59 215 PMID: 21297302
If you know of a relevant reference for TM 5275 sodium salt, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: TM 5275 sodium salt, TM 5275 sodium salt supplier, TM5275, sodium, salt, plasminogen, activator, inhibitors, 1, PAI-1, inhibits, orally, bioavailable, Plasminogen, Activator, Inhibitor, 5769, Tocris Bioscience
1 Citation for TM 5275 sodium salt
Citations are publications that use Tocris products. Selected citations for TM 5275 sodium salt include:
Sun-Hee et al (2022) Secretory SERPINE1 Expression Is Increased by Antiplatelet Therapy, Inducing MMP1 Expression and Increasing Colon Cancer Metastasis. Int J Mol Sci 23 PMID: 36076991
Do you know of a great paper that uses TM 5275 sodium salt from Tocris? Please let us know.
Reviews for TM 5275 sodium salt
There are currently no reviews for this product. Be the first to review TM 5275 sodium salt and earn rewards!
Have you used TM 5275 sodium salt?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Angiogenesis in Cancer Poster
This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.